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TherapyAbstract Over the past half-century, biomaterials have been used in orthopaedic surgery world
widely, but orthopaedic implant-associated infections (OIAIs) are still a puzzle for orthopaedic sur-
geons, which may result in prolonged hospitalisation, poor functional status and high costs. The
presence of implants increases the risk of microbial infection; moreover, the formation of bacterial
bioﬁlm leads to a higher resistance to antibiotics and local immune response. In such cases, conven-
tional systemic delivery of drugs seems to be fairly inefﬁcient and out-dated. Owing to this, debride-
ment and/or removing the implant always become the only solution. Hence, it needs a simple,
minimally invasive and effective therapy to eradicate the problem. There are abundant evidences
showing that extracorporeal shock wave therapy (ESWT) has favourable effects on stimulating
callus formation, inducing angiogenesis, promoting osteogenesis and relieving pain. Studies also
indicated that ESWs have a signiﬁcant bactericidal effect on bacterial strains of bone- and
implant-associated infections. Therefore, a hypothesis proposed herein is that ESWT may well be
an effective adjuvant treatment for OIAI by controlling infection, inducing bone regeneration
and promoting re-osseointegration.
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Background
In recent decades, with the advancements in the manufacture
of synthetic biomaterials and in surgical techniques, orthopae-
dic implants have been used widely in orthopaedic operations.
Up till 2010, there have been more than 4.4 million people im-
planted with at least one internal ﬁxation device and more than
1.3 million people having at least an artiﬁcial joint.1 Despite
the excellent effects of implant therapy, orthopaedic implant-
associated infections (OIAIs) are still conundrums for ortho-
paedic surgeons with an average rate about 2–5%,2 which
may lead to prolonged hospitalisation, poor functional status
and high costs. The results of current treatments for OIAI
are unsatisfactory; hence, removal of the implant becomes a
global issue and the ‘key’ to the solution.
General information regarding OIAIs
OIAIs are deﬁned as inﬂammatory processes associatedwith for-
eign bodies such as ﬁxation devices and prostheses affecting
bones and soft tissues,3 which may lead to prolonged treatment
cycles, more adverse reactions, high risk of complications such as
chronic osteomyelitis and septicaemia, poor functional status
and even disability.2,4 According to Association of the Study
of Internal Fixation (AO/ASIF),2 about 50% of all nosocomial
infection cases were associated with implants in the US, and
the average cost of treatment reached 15,000–30,000 dollars.
Actually, OIAIs are the result of bacterial bioﬁlm formation at
the implantation site.5 Pathogenic microorganisms, particularly
Staphylococcus aureus andStaphylococcus epidermidis, which are
the prime culprits of OIAI, have been found to be on the surfaces
of approximately 90% of all implants.6 Thus the implantation
itself is always accompanied with the risk of bacterial infection,
especially for the ﬁxation of open fractures and joint-revision
surgeries, which are of more tissue damage and circulation
destruction.7 On the other hand, it was found that the presence
of implants could decrease the minimal infecting dose of
S. aureus 100,000-fold.8 Moreover, the susceptibility of bioﬁlm
cells to antibiotics is 10- to 1,000-fold less than that of the same
bacterium grown in free-ﬂoating culture9 and the impaired blood
circulation might deprive antibacterial agents and the local im-
mune response of the access to the infected tissues.10 Under this
circumstance, conventional systemic antibiotic therapy is looked
upon as useless inevitably since it may cause systemic toxicity; as
a result, it is obvious that the only feasible solution to the prob-
lem is debridement and removal of the implant.11 In spite of this,
the recurrent infection rate yet remains at a high level.12 What is
more, non-surgical strategies, such as ultrasonic waves, eddies,
enzyme treatments and electrical stimulation, are regarded to
be not efﬁcient in eliminating the infections, whilst the effects
of functional nanostructured coatings are still need to be evalu-
ated as well.13 Therefore, seeking for an easy and effective meth-
od focussed on eradicating OIAI is a task of top priority.
The inﬂuences of EWST on bone and bacteria
ESWs are high-energy single sonic pulses generated underwater
by high-voltage explosion and vapourisation, which propagate
in a wavelike manner in water-like soft tissues with minimaltissue absorption and no thermal effect.14 Shock waves are
characterised by a high peak pressure (100 MPa) with an energy
ﬂux density in the range of 0.003–0.890 mJ mm2.15. When the
pressure waves meet an interface of different impedance in their
ﬂow, the energy will be released to generate shear forces and
cavitation, which may then cause multi-biological effects. In re-
cent years, ESWT has been becoming increasingly popular in
orthopaedics, though this technique was originally developed
for the treatment of nephrolithiasis in 1980.16 Shock waves
have been demonstrated to have great value in the treatment
of bone and soft-tissue disorders, such as tennis elbow,17 tendi-
nitis calcarea of the shoulder,18 delayed or nonunion of frac-
tures,19 femoral head necrosis,20 osteoporosis21 and chronic
ulcers,22 due to their favourable effects on stimulating callus
formation, promoting osteogenesis, inducing neo-vascularisa-
tion, inhibiting inﬂammation and relieving pain.
It has already been evidenced that shock waves have a sig-
niﬁcant energy-dependent or impulse number-dependent bac-
tericidal effect on both Gram-positive and Gram-negative
strains in vitro, particularly bacterial strains of bone- and im-
plant-associated infections such as S. aureus and S. epidermi-
dis, with marked reduction of viable bacterial counts by up
to 99%.23–25 Besides, Horn et al. also found that high-energy
shock waves could still inhibit bacterial growth even under
growth-preventing conditions (cation-adjusted Muller Hinton
broth, CAMHB),26 which provided a favourable experimental
basis for the application of ESWT in vivo.
The hypothesis
Considering the signiﬁcant bactericidal effect and the favour-
able effects on stimulating callus formation, inducing angio-
genesis and promoting osteogenesis of ESWT, a hypothesis
can be posed that it may be an easy and effective adjuvant
treatment for OIAI by means of controlling infection, inducing
bone regeneration and promoting re-osseointegration, with or
without conventional systemic delivery of drugs. Taking into
account the achievements obtained and the obstacles faced
by OIAI therapy, it is believed that ESWT is an up-dated
and non-invasive approach that is worth using.
Evaluation of the hypothesis
The exact mechanisms and modes of action of ESWT
With respect to the molecular mechanisms, abundant studies
have indicated that shock waves could stimulate the early
expression of not only osteogenic factors (bone morphogenetic
protein, BMP; alkaline phosphatase, ALP; osteocalcin, OC;
osteopontin, OPN; transforming growth factor-b1, TGF-b1;
and insulin-like growth factor, IGF)27–31 which help promote
growth and differentiation of bone-marrow stromal cells to-
wards osteoprogenitor cells, thus then contributing to bone
regeneration and re-osseointegration, but also angiogenic fac-
tors (ﬁbroblast growth factor, FGF; endothelial nitric oxide
synthase, eNOS; vascular endothelial growth factor, VEGF;
and proliferating cell nuclear antigen, PCNA)29,32 contributing
to revascularisation. In addition, it was found that the mecha-
nisms of anti-inﬂammatory action of shock waves might in-
clude enhancement of eNOS activity, increase in NO
production, suppression of nuclear transcription factor-jB
(NF-jB) activation and elevation of anti-inﬂammatory factors
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In previous investigations, researchers found that shock
waves had the potential to remove bioﬁlm by three log steps33
and could enhance the susceptibility of bioﬁlm cells to antimi-
crobial agents in vitro.34 Furthermore, proven effects of ESWT
such as revascularisation and tissue regeneration might also be
beneﬁcial to improving the access of antibacterial agents and lo-
cal immune response to the infected tissues,10 and unaltered
antibiotic efﬁcacy after ESWT has been demonstrated in vitro.26
Although various studies have described the bactericidal ef-
fect of ESWs, the exactmode of action still remains as amystery.
So far, in contrast to eukaryotic cells, simply few studies with
reputation known to the authors investigating the molecular
or cellular mechanisms of shock waves have been made on bac-
teria. Horn et al.35 explored that the bacterial cell walls would
still remain intact after ESWT due to the stability of the murein
layers composed of covalently boundmacromolecules, and they
also considered that the permeabilisation of bacterial cells might
have only a minor impact, if any, on the bactericidal effect of
ESWs. Therefore, compared with extracellular mechanisms,
intracellular modes of action, such as formation of free radicals,
modulation of gene activity and destruction of cell organelles or
double-stranded DNA (dsDNA), some of which have already
been reported in eukaryotic cells,36 should be aspects of further
investigations. Additionally, as mentioned above, ESWs could
break up the bioﬁlm layers and disperse individual bacteria into
surrounding tissues, leading to increased susceptibility to anti-
bacterial agents34 and the access of antibiotics and inﬂamma-
tory cells to avascular areas could be improved by neo-
vascularisation and tissue regeneration.10 However, it still re-
mains unclear whether ESWT has direct favourable effects on
the immune response.
The safety of ESWT
Although abundant studies describing the effects of ESWT on
a multitude of orthopaedic disorders exist, no accurate data
are available concerning evaluating the potential therapeutic
role of ESWT in destroying bacteria in humans. In fact, in-
fected target areas are still considered as a contraindication
for ESWT because of the risk of bacterial spreading which
might induce secondary abscess formation and bacteraemia
after ESWT. However, the risk of treating an infected target
area with ESWT has not yet been adequately studied in any
controlled experiment, and only single cases of secondary
infections have been documented after shockwave lithotripsy
of infected kidney stones.37,38 On the other hand, as for the
controversy over the transient bacteraemia after ESWT of in-
fected stones and the necessity of prophylactic antibiotics dur-
ing extracorporeal shockwave lithotripsy, it was hypothesised
that lesions in the mucous membrane caused by sharp stone
fragments rather than ESWs themselves might contribute to
the bacterial spreading.39–41 Additionally, one study by Scha-
den applying high-energy ESWs on both septic and aseptic
nonunions reported a healing rate of 77% for both types of
nonunion without any ESWT-related side effects.19 Further-
more, Gollwitzer et al.10 observed positive effects of ESWT
on bone infections in a rabbit model of osteomyelitis without
bacterial spreading and worsening of infection. Therefore, lo-
cal infections should no longer be considered to be a contrain-
dication for ESWT of orthopaedic disorders.Potential clinical signiﬁcance
Orthopaedic implants are extremely useful for the restoration
in patients with fracture, osteoarthritis or other orthopaedic
disorders. In order to improve the success rate, the application
of ESWT into the treatment using orthopaedic implants may
reduce the incidence of OIAI with its bactericidal effect; the
rehabilitation time may also be shortened because of the accel-
eration of bone regeneration.
When OIAI occurs, ESWT may act as an adjuvant therapy
by controlling infection, inducing bone regeneration and pro-
moting re-osseointegration with the aim of avoiding repeated
surgeries such as debridement and enhance the longevity of
the prostheses.
ESWT is non-invasive, characterised by simple operation,
short duration of each treatment, precise focussing, minimal
damage to surrounding tissues and rare incidence of complica-
tions which can be negligible.42
Testing the hypothesis
Respecting the application of ESWT in clinical cases, further
investigations are necessary to conﬁrm the hypothesis. Con-
trolled animal experiments should be done ﬁrstly to verify the
effectiveness of ESWT in controlling infection, promoting bone
and soft-tissue regeneration and relieving pain so as to investi-
gate the optimal energy ﬂux density, impulse number and treat-
ment frequency. At the same time, negative side effects could be
observed in vivo and its incidence rate should be minimised.
Additionally, the exact mechanisms of killing bacteria of
ESWs, especially intracellular modes of action, should be clar-
iﬁed; meanwhile the inﬂuences of ESWs on immune response
are also need to be investigated. When the concerns are clear,
we believe that ESWT could become an important option in
the prevention and treatment of OIAI and might be helpful
to other bone and soft-tissue infectious diseases.
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What do we already know about the subject?
ESWT has a signiﬁcant bactericidal effect and other
biological effects such as stimulating callus formation,
inducing angiogenesis and promoting osteogenesis.
What does your proposed theory add to the current
knowledge available, and what beneﬁts does it have?
ESWT could prevent and treat OIAI by controlling
infection, inducing bone regeneration and promoting
re-osseointegration. It is a simple and non-invasive
therapy that could avoid repeated surgeries such as
debridement, shorten the rehabilitation time, promote
early function training and reduce the costs.
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Controlled animal experiments should be done ﬁrst to
verify the effectiveness and safety of ESWT and to
investigate the optimal energy ﬂux density, impulse
number and treatment frequency. The mechanisms of
killing bacteria and the inﬂuences on the immune
response of ESWT should also be clariﬁed through
multi-basic study.Acknowledgements
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